Viewing data from:

DEXAMETHASONE ACETATE

ANDA

DEXAMETHASONE ACETATE | A087711 | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain2 active DMFs4 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

EUROAPI FRANCEDEXAMETHASONE ACETATE ANHYDROUS USP

DMF 27361976

PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INCDEXAMETHASONE ACETATE USP ANHYDROUS MICRONIZED

DMF 45321982

DBI INCInactiveDEXAMETHASONE ACETATE

DMF 11421968

ORGANON INCInactiveDEXAMETHASONE ACETATE

DMF 28151976

CYCLO PRODUCTS INCInactiveDEXAMETHASONE ACETATE

DMF 37371980

HOECHST MARION ROUSSEL SAInactiveDEXAMETHASONE ACETATE USP MONOHYDRATE

DMF 115871995

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 16MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: May 24, 1982

No patent or exclusivity listings for this strength.